Trial Profile
The Pharmacokinetic/Pharmacodynamic Study of Biapenem combination with Fosfomycin sodium against Acinetobacter baumannii infection in Thai Critically Ill
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Biapenem (Primary) ; Fosfomycin (Primary)
- Indications Acinetobacter infections; Gram-negative infections
- Focus Pharmacokinetics
- 18 Jun 2018 New trial record